These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 9297428)
1. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity]. Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428 [TBL] [Abstract][Full Text] [Related]
2. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight]. Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752 [TBL] [Abstract][Full Text] [Related]
3. Early treatment of premature infants with recombinant human erythropoietin. Messer J; Haddad J; Donato L; Astruc D; Matis J Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820 [TBL] [Abstract][Full Text] [Related]
4. [Prophylaxis of anemia of prematurity with erythropoietin. Case control study]. de la Torre Aguilar M; Gascón Jiménez FJ; Zapatero Martínez M; Guzmán Cabañas J; Huertas Muñoz D; Ruiz González D; Jaraba Caballero P An Esp Pediatr; 2000 Sep; 53(3):243-8. PubMed ID: 11083968 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in the treatment of anemia of prematurity. Chen JY; Wu TS; Chanlai SP Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and prematurity--where do we stand? Carbonell-Estrany X; Figueras-Aloy J; Alvarez E J Perinat Med; 2005; 33(4):277-86. PubMed ID: 16207112 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis]. Schefels J; Merz U; Hörnchen H Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():1-5. PubMed ID: 10612190 [TBL] [Abstract][Full Text] [Related]
9. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627 [TBL] [Abstract][Full Text] [Related]
10. [Effects of recombinant human erythropoietin in the treatment of anemia of prematurity]. Rosati E; Latini G; De Mitri B; Quartulli L; Caliandro P Pediatr Med Chir; 1995; 17(1):45-8. PubMed ID: 7739926 [TBL] [Abstract][Full Text] [Related]
11. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier. Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616 [TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284 [TBL] [Abstract][Full Text] [Related]
15. Enteral erythropoietin increases plasma erythropoietin level in preterm infants: a randomized controlled trial. Pasha YZ; Ahmadpour-Kacho M; Hajiahmadi M; Hosseini MB Indian Pediatr; 2008 Jan; 45(1):25-8. PubMed ID: 18250501 [TBL] [Abstract][Full Text] [Related]
16. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity. Bader D; Kugelman A; Maor-Rogin N; Weinger-Abend M; Hershkowitz S; Tamir A; Lanir A; Attias D; Barak M J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837 [TBL] [Abstract][Full Text] [Related]
17. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin]. Lauterbach R; Kachlik P; Pawlik D; Bajorek I Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506 [TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]